(Q42598223)

3 November 2017

title

Average annual drug cost and its determinants in a population based cohort of HIV-positive adult men and women (English)

1 reference

3 November 2017

2

1 reference

3 November 2017

7

1 reference

3 November 2017

Anis AH

1

1 reference

3 November 2017

Yip B

3

1 reference

3 November 2017

Wang XH

4

1 reference

3 November 2017

Montaner JS

5

1 reference

3 November 2017

O'Shaughnessy MV

6

1 reference

3 November 2017

publication date

1 March 1998

1 reference

3 November 2017

1 reference

3 November 2017

volume

13

1 reference

3 November 2017

issue

3

1 reference

3 November 2017

page(s)

327-336

1 reference

The economic impact of AIDS in the United States

3 November 2017

cites work

1 reference

12 December 2020

The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe

1 reference

12 December 2020

Effect of changing patterns of care and duration of survival on the cost of treating the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland

1 reference

12 December 2020

Regression analysis for correlated data

1 reference

12 December 2020

The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States

1 reference

12 December 2020

Modelling the Cost Effectiveness of Lamivudine/Zidovudine Combination Therapy in HIV Infection

1 reference

12 December 2020

Interim proposal for a WHO Staging System for HIV infection and Disease

1 reference

12 December 2020

Models for longitudinal data: a generalized estimating equation approach

1 reference

12 December 2020

Current controversies in the treatment of HIV infection and AIDS. An economic perspective

1 reference

12 December 2020

The usage and costs of health services for HIV infection in Australia

1 reference

12 December 2020

Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.

1 reference

12 December 2020

Studying the cost of HIV-related illnesses: reflections on the moving target

1 reference

12 December 2020

The lifetime cost of treating a person with HIV.

1 reference

12 December 2020

Combination antiretroviral therapy in HIV infection. An economic perspective

1 reference

12 December 2020

Design and assessment of cost-effectiveness studies in AIDS populations

1 reference

12 December 2020

Impact of immunosuppression on health care use by men in the Multicenter AIDS Cohort Study (MACS)

1 reference

12 December 2020

Medical care costs of patients with AIDS in San Francisco.

1 reference

12 December 2020

Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols.

1 reference

12 December 2020

Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection

1 reference

12 December 2020

10.2165/00019053-199813030-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

3 November 2017

1043205062

0 references

Fatcat ID

release_4g7325r2c5f25ermm5b5fge2w4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4g7325r2c5f25ermm5b5fge2w4

24 November 2022

mapped directly with Wikidata item

1 reference